Fig. 2From: Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world studyKaplan-Meier curve of PFS in the general populationBack to article page